Organigram On Pace To Beat Tilray And Hexo In QoQ Sales Growth As Canadian Rec. Sales Reach $275.6M

As COVID-related restrictions begin to ease across the globe, some industries are feeling the benefits more than others. When it comes to Canadian recreational cannabis sales, new Hifyre scanner data reveals a 10% improvement sequentially, noted Cantor Fitzgerald’s Pablo Zuanic in his latest industry report.

The analyst was projecting more of an accelerated growth rate compared to the second-quarter growth pace, but that didn’t happen despite cannabis shops now receiving in-store traffic.

Hifyre estimated August sales reached CA$347 million ($275.6 million), representing

2% month-over-month growth, after hitting CA$339 million in July (which was up 7% from June). The average monthly sales for both months amount to CA$343 million, which is 10% higher than the second quarter monthly average, explained Zuanic.

“If we assumed September is flat month-over-month, this would still imply about 11% sequential quarter-over-quarter growth,” the analyst detailed, adding that this is neither good nor bad, just not “accelerated” as he was expecting.

The report also revealed that pre-rolls have driven growth accounting for 24% of sales, improving 27% over the second quarter monthly average. Flower sales were up only 2%, accounting for almost half of the sales, while vapes (13% of sales) and edibles (5% of sales) jumped 9% and 20%, respectively. Concentrates sales improved 24% and accounted for 4% of industry sales.

Performance By Company

Industry giants had various performances, with Organigram OGI and Auxly 

CBWTF standing out and outperforming with 30% and 22%, respectively, Zuanic highlighted.

  • Cronos Group CRON – Up 50%
  • Organigram – Up 30%;
  • Auxly – Up 22%;
  • Tilray TLRY – Up 6%;
  • HEXO HEXO – Up 7%;
  • Village Farms Intl VFF – Up 7%;
  • Canopy Growth CGC – Down 12% ;
  • Aurora Cannabis ACB – Down 16%;
  • Sundial Growers ( NASDAQ: SNDL) – Down 4%.

“In terms of companies reporting July or August quarters, we calculate Organigram is on pace for a significant beat with August quarter sales up 44% sequentially, while HEXO (July quarter) and Tilray (August) point to low single-digit pro forma growth,” noted Zuanic.

Market Share By Company 

  • Tilray – 15.3% share (consisting of Aphria’s 11.1% and Tilray’s 4.2%);
  • HEXO (including Hexo and recently acquired Redecan, Zenabis and 48North) - 12.7% share;
  • Canopy Growth (counting Supreme) – 10.2% share;
  • Organigram – 7.1% share;
  • Village Farms Intl – 7.0% share;
  • Auxly – 5.3% share;
  • Cronos Group – 4.2% share;
  • Aurora Cannabis – 3.9% share;
  • Sundial Growers – 1.9% share. 

Price Action 

Organigram’s shares were trading 0.75% lower at $2.63 per share during Tuesday's pre-market session. 

Photo: Courtesy of Visual Stories || Micheile on Unsplash

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorCannabisNewsMarketsAnalyst RatingsCanadian cannabis salesCantor FitzgeraldPablo Zuanic
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

The Top Cannabis Event In New Jersey

Join the Benzinga Cannabis Market Spotlight in New Jersey on June 17th! Grow your business, raise money and capitalize on the booming NJ recreational market. Don’t miss this must-attend event in New Brunswick. Secure your tickets now. Very few spots are left. Use the code "JAVIER20" for 20% off!


Loading...